IL9 and asthma: Recent work has shown that another epithelial-derived alarmin, called TL1A, can act with IL-33 to increase IL-9 production by ILC2s, which then becomes pathogenic, suggesting that IL-9 might represent an interesting target in asthma [27, 30].